Surgisphere claimed to have analyzed data from six continents and hundreds of hospitals that had treated patients with HCQ or CQ in real time. Someone persuaded the Lancet and the New England Journal of Medicine to publish two Surgisphere studies in separate articles on May 1 and 22. Like the other Gates-supported studies, the Lancet article portrayed HCQ as ineffective and dangerous.
